Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	1/30/2008 2:01:16 PM
	of 3044

Priority review for front line MM +++++++++++++++++ Millennium:FDA OKs Priority Review For New Velcade Indication DOW JONES NEWSWIRES January 30, 2008 7:35 a.m. Millennium Pharmaceuticals Inc. (MLNM) said Wednesday the Food and Drug Administration granted priority review for Velcade in patients with newly diagnosed multiple myeloma. The priority review designation puts the drug on track for a potential label expansion decision by June 20, the company said. In the U.S., Velcade is currently indicated for the treatment of patients with multiple myeloma who have received at least one prior therap

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next